Resmed taps Schwartz as chief investor relations officer
By HME News Staff
Updated 9:07 AM CDT, Thu April 24, 2025
SAN DIEGO – Resmed has named Salli Schwartz as chief investor relations officer, where she will lead the company’s global investor relations function and report to Mick Farrell, chairman of the board and CEO. She joins Resmed from Illumina, where she served as the head of investor relations. In that role, she led the company’s investor engagement strategy, representing the company’s response to shareholders’ perspectives on corporate strategy, capital allocation, and financial performance. “Salli is a seasoned financial leader with a proven track record of driving investor relationships supporting business strategy and capital efficiency,” said Farrell. “Her leadership and expertise will be critical as we advance our 2030 strategy to drive shareholder value and empower 500 million people worldwide to achieve their full health potential.” Prior to Illumina, Schwartz served as head of investor relations and treasurer at MSCI, where she managed investor communications as well as a portfolio of more than $2 billion in cash and short-term investments, and more than $4 billion in high-yield debt. “I am excited to join Resmed at such a pivotal moment in its strategy to make better sleep and breathing health more accessible around the world,” said Schwartz. “I look forward to partnering with our leadership team and our shareholders to communicate and advance Resmed’s vision and financial targets.”
Comments